Search Results

Site Search

Research Archives - Page 13 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Newsroom - Insights

The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at newsbureau@mayo.edu, attention: Mayo Clinic Laboratories.

The Importance of Sales Call Planning in Laboratory Outreach Sales - Insights

Sales is a vital component of a thriving laboratory outreach program. It requires a unique skill set and a dedicated focus on advocating the value of your laboratory and its ability to deliver reliable, high-quality services to your...

Targeted panel boosts accuracy of hereditary pancreatitis testing: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C. - Insights

Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test...

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D. - Insights

Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of...

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D. - Insights

Tobacco use is the leading cause of preventable death in the United States. In this test-specific episode of the "Answers From the Lab" podcast, Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients...

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights

Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test...

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC - Insights

Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases the risk for many...

Employee Wellness - Insights

Balancing work, family, and personal life can be very challenging for employees. Dawn Doherty, Education Program Coordinator at Mayo Clinic, highlights the importance of employee wellness and identifies resources that may be helpful in your...

People Archives - Page 8 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Education - Insights

Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and

Metagenomics - Insights

Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.

Examining dendritic cells to uncover immunity defects - Insights

Dendritic cells play a crucial role in the body's immune response. Research has shown that too few of these cells in the blood may signal a defect in innate immunity. Up to this point, however, no clinical test has been available to count...

Testing Archives - Page 18 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Precision therapeutics can individualize depression treatment - Insights

Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D., explain how precision therapeutics can improve treatment for patients with major depressive disorder. The optimal antidepressant medication and dose vary among individuals. Pharmacogenomic...

MCL @Work: Wendy Sempf - Insights

Wendy is a clinical laboratory technologist who works in the Hematopathology Morphology Laboratory at Mayo Clinic Laboratories. Although she’s worked with Mayo Clinic since 1989, her greatest passion is serving others throughout the...

Top 5 Tech Tools Used to Create and Facilitate Education - Insights

In today’s world, technology is at the forefront of learning, and as such, educators must decipher what the best tech tools are to deliver the content to their learners. With so many software and technology options out there, where do you...

Diagnosis and inflammation monitoring - Insights

Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.

Histoplasma/Blastomyces - Insights

Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D. - Insights

Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...

numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology - Insights

numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...

MCL - Neurology Specialty Testing Client Test Request - MC0767-02A

MCL - Neurology Specialty Testing Client Test Request

Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights

Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.

Invasive fungal infection - Insights

Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.

Therapeutic drug monitoring - Insights

Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.

Autoimmune profile updates - Insights

Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...

5 Tips for Effectively Surveying Lab Customers - Insights

Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...

Weeding Through the Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights

In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC) to creatinine ratio along with a...

6 Ways Individualized Medicine Is Advancing Patient Care - Insights

Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, presented six ways precision medicine has further advanced into patient care over the past year.

Cardiovascular Events in Patients With or Without Coronary Artery Disease

A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...

Building an effective supply provision program - Insights

Having an efficient and effective supply provision program is a cornerstone for laboratory outreach program success. By providing adequate specimen collection supplies in compliance with current regulations, the outreach laboratory-customer...

Featured - Insights

This featured section focuses on events, updates, and items of interest for Mayo Clinic Laboratories’ clients, health care providers, lab staff, and the public.

People Archives - Page 35 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Week in Review: October 11 - Insights

Top highlights include: Discussions around flu season, teen vaping, spotting signs of cognitive impairment, and DNA tests.

Research Archives - Page 12 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 11 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

People Archives - Page 13 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Week in Review: March 18 - Insights

Today's Highlights Include: A new strategy for staying one step ahead of the virus, Pfizer CEO says another Covid booster will be needed, and Senate votes to make daylight saving time permanent.

Testing Archives - Page 5 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) - Insights

Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV....

Appropriate Use of Gastrointestinal Pathogen Panel by PCR [Utilization Spotlight] - Insights

Infectious diarrhea is a common and usually self-limited illness. While most patients with infectious causes of diarrhea will get better on their own, there are certain scenarios in which testing is indicated. The The FilmArray...

Testing Archives - Page 9 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 10 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Dr. Morice Shares Trends and Predictions for 2025 - Insights

The healthcare and diagnostics landscape is poised for transformative changes driven by technological advancements and evolving market dynamics.

Three core elements of exceptional customer service - Insights

Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.

5 Steps to Improve Communication in Laboratory Outreach - Insights

Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D. - Insights

Sean Pittock, M.D., explains how Mayo Clinic Laboratories' novel Ma2 test aids diagnosis of autoimmune neurology disorders that are often caused by underlying cancer. Rapid diagnosis is key to preventing significant disability and disease.

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC - Insights

Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment...